Fortis Healthcare is currently trading at Rs. 133.55, up by 11.75 points or 9.65% from its previous closing of Rs. 121.80 on the BSE.
The scrip opened at Rs. 128.40 and has touched a high and low of Rs. 136.00 and Rs. 127.00 respectively. So far 677513 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 136.00 on 15-Sep-2014 and a 52 week low of Rs. 93.10 on 03-Mar-2014.
Last one week high and low of the scrip stood at Rs. 136.00 and Rs. 117.50 respectively. The current market cap of the company is Rs. 6189.79 crore.
The promoters holding in the company stood at 71.34% while Institutions and Non-Institutions held 9.14% and 19.52% respectively.
Fortis Healthcare’s subsidiary -- Fortis Healthcare Singapore -- is reportedly planning to divest its entire stake in diagnostic and molecular imaging unit RadLink-Asia. Malaysia’s IHH Healthcare Bhd, Asia’s largest hospital operator by stock market value, will buy the assets for 137 million Singaporean dollars (around $108.5 million).
The deal will be successfully closed following the necessary statutory and regulatory approvals as per local requirements. J P Morgan and Religare Capital Markets acted as financial advisors to Fortis for this transaction.
Fortis Healthcare is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 9 countries.
